Drug
Cvncov
Cvncov: highest development phase Phase 2/3, developed by CureVac. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- CureVac
Trials
| Drug | Phase | Indication |
|---|---|---|
| CVnCoV NCT04652102 | Phase 2/3 | Covid19 |
Latest
No recent events.
Follow Cvncov on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.